PAVmed Inc. (PAVM)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$40.2M
Stockholders' Equity
$35.0M
Cash & Equivalents
$3.8M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, PAVmed Inc. reported revenue of $33,000, net income of -$5.4M, and total assets of $40.2M. Every figure below is taken directly from PAVmed Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2021–FY2025 · as reported

$39.8M-$24.6M-$89.0M
FY2021FY2022FY2023FY2024FY2025
Revenue$71,000Net income$401,000
FY2021 revenue
$500,000
FY2025 revenue
$71,000

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$71,000$401,000
FY2024$3.0M$39.8M
FY2023$2.5M-$64.2M
FY2022$377,000-$89.0M
FY2021$500,000-$50.3M
FY2020—-$34.3M
FY2019—-$16.5M
FY2018—-$18.0M
FY2017—-$9.5M
FY2016—-$5.7M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 22, 2026on EDGAR ↗
8-KSep 9, 2026on EDGAR ↗
8-KAug 14, 2026on EDGAR ↗
10-QAug 13, 2026on EDGAR ↗
8-KJun 24, 2026on EDGAR ↗
8-KMay 15, 2026on EDGAR ↗
10-QMay 14, 2026on EDGAR ↗
DEF 14AApr 30, 2026on EDGAR ↗
8-KMar 30, 2026on EDGAR ↗
8-KMar 27, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$40.2Msource ↗
Stockholders’ Equity$35.0Msource ↗
Cash & Equivalents$3.8Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$33,000source ↗
Net Income-$5.4Msource ↗
Operating Income-$7.0Msource ↗
Gross Profit-$89,000source ↗
Cost of Revenue$122,000source ↗
R&D Expense$2.1Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.87source ↗
EPS (basic)$-0.87source ↗
Shares Outstanding8.0Msource ↗
Cash from Operations-$2.7Msource ↗
Cash from Financing$0source ↗
Cash from Investing-$13,000source ↗

Restatement history

Point-in-time

No material restatements detected across 256 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches PAVM’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PAVM

MCP tool: get_sec_fundamentals ticker=PAVM

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PAVM/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=PAVM as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PAVM/history

MCP tool: get_fundamentals_history ticker=PAVM

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/PAVM

MCP tool: get_financial_health ticker=PAVM

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.